ROS-Related miRNAs Regulate Immune Response and Chemoradiotherapy Sensitivity in Hepatocellular Carcinoma by

Yangtao Xu1, Xiaoqin He1, Junjian Deng1

  • 1Cancer Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China 430060.